Tech & Gadgets

RFK Jr. wants Americans to use peptides that were banned over safety risks

26 sec read227 views1 listen

Robert F. Kennedy Jr., the anti-vaccine Health Secretary, is advocating for lifting FDA restrictions on over a dozen injectable peptide treatments previously banned due to safety risks. This push matters as it could lead to increased use of unproven and potentially dangerous peptides among consumers seeking alternative health solutions. Watch for potential changes in FDA policy regarding these treatments.

Read the full article at Ars Technica

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Fitness & WellnessSep 931 sec read

First-in-Class Orexin Agonist Secures Global Approvals for Narcolepsy Type 1

ORZEYFUL (oveporexton), the first oral orexin receptor 2 agonist for narcolepsy type 1, has secured approvals in Japan, China, and the US. This marks a shift from symptom management to addressing the underlying orexin deficiency, offering significant...

Ali Nemati

Biotech & PharmaAug 2723 sec read

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer

Aprea Therapeutics is accelerating enrollment in its Phase I trial of APR-1051, a WEE1 kinase inhibitor, after observing early signs of clinical activity. This expansion aims to gather more data on the drug's efficacy and safety, particularly for pat...

Ali Nemati

Biotech & PharmaJun 828 sec read

STAT+: Pharmalittle: We're reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more

New clinical data shows that combining targeted oncology drugs vopimetostat and daraxonrasib produces durable responses in pancreatic cancer patients without the use of traditional chemotherapy. Meanwhile, safety reports for the next-generation obesi...

Ali Nemati